drugset / Trial / NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open-label, exploratory clinical study to evaluate the efficacy and safety of IASO207 Injection in patients with Relapsed/Refractory B-cell Malignancies。
Timeline
- Start
- 2026-05-29
- Primary completion
- 2029-04-30
- Completion
- 2042-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IASO207 | Unknown | 5e+08 unknown | Intravenous |
| Subject | IASO207 | Unknown | 1e+09 unknown | Intravenous |
| Subject | IASO207 | Unknown | 2e+09 unknown | Intravenous |